This special issue is dedicated to several topics related to the pharmacological management of cardiovascular (CV) risk factors in both primary and secondary prevention. In particular, the role in controlling high blood pressure and lipid has been investigated in different settings.
Alexia Katsarou, Marios M. Vryonis, Athanase D. Protogerou, Evangelos C. Alexopoulos, Apostolos Achimastos, Dimitrios Papadogiannis, George Chrousos, Christina Darviri
Discussion(0)
No comments yet. Be the first to comment.